CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd 2023; 83(05): 602-611
DOI: 10.1055/a-2049-2976
GebFra Science
Original Article

Does Antenatal MgSO4 Administration to the Mother in the Event of Imminent Premature Birth Reduce the Occurrence of Infantile Cerebral Palsy in the Child? – An Umbrella Review

Artikel in mehreren Sprachen: English | deutsch
Charlotte Binder
1   Institut für Gesundheitswissenschaften, Abteilung Hebammenwissenschaft, Universitätsklinikum Tübingen, Tübingen, Germany
,
Pauline Schmid
1   Institut für Gesundheitswissenschaften, Abteilung Hebammenwissenschaft, Universitätsklinikum Tübingen, Tübingen, Germany
,
Harald Abele
1   Institut für Gesundheitswissenschaften, Abteilung Hebammenwissenschaft, Universitätsklinikum Tübingen, Tübingen, Germany
2   Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen, Germany
,
Joachim Graf
1   Institut für Gesundheitswissenschaften, Abteilung Hebammenwissenschaft, Universitätsklinikum Tübingen, Tübingen, Germany
› Institutsangaben

Abstract

Introduction Premature births have a significantly increased risk of developing cerebral palsy. This clinical picture involves great restrictions and impairments in the lives of the children and their families. Its prevention is therefore of great importance. One method of neuroprotection to reduce the rate of infantile cerebral palsy is the antenatal administration of magnesium sulfate to the mother. The aim of this paper is to present the current state of research of existing reviews and meta-analyses on the topic and to review the evidence for this intervention.

Material and Methods A literature search was conducted within the framework of an umbrella review in the electronic database PubMed in February 2022 to identify all relevant publications on the topic. The search was structured using the PRISMA statement. The important methodological characteristics and the results of the studies were then extracted. In addition, a quality assessment of the studies was performed using the AMSTAR score.

Results Two systematic reviews with meta-analysis, one systematic review, and one individual participant data meta-analysis were included in this study. The total number of subjects was n = 6178. The publications conclude that the antenatal administration of magnesium sulfate to the mother significantly reduces the risk of cerebral palsy in preterm infants. Due to the high quality of 3 of the 4 studies, a high level of evidence can be assumed.

Conclusion The evidence for antenatal magnesium sulfate administration for the prophylaxis of cerebral palsy in preterm infants is high. However, further research is needed to determine which doses of magnesium and up to which gestational age the administration is useful.

Supporting information



Publikationsverlauf

Eingereicht: 16. September 2022

Angenommen nach Revision: 04. März 2023

Artikel online veröffentlicht:
04. Mai 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany